Anika Therapeutics (ANIK) Other financing activities (2010 - 2025)
Anika Therapeutics' (ANIK) quarterly Other financing activities came in at $239000.0 in Q4 2025, down 19.53% year-over-year from $297000.0 in Q4 2024, and down 8.43% quarter-over-quarter from $261000.0 in Q2 2025.
Powered by 
Analysis
Anika Therapeutics (ANIK) Other financing activities (2010 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has reported Other financing activities for 16 consecutive years, with $239000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other financing activities fell 19.53% year-over-year to $239000.0 in Q4 2025; TTM through Dec 2025 was $500000.0, a 29.38% decrease from a year earlier, with the FY2025 full-year figure at $500000.0, down 29.38% from the prior year.
- Other financing activities was $239000.0 for Q4 2025 at Anika Therapeutics, down from $261000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $650000.0 in Q4 2022 and troughed at $7000.0 in Q1 2023.
- A 5-year average of $292769.2 and a median of $297000.0 in 2024 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities slumped 92.17% in 2021 and surged 470.18% in 2022, its largest moves.
- Over 5 years, Other financing activities stood at $114000.0 in 2021, then surged by 470.18% to $650000.0 in 2022, then slumped by 46.31% to $349000.0 in 2023, then declined by 14.9% to $297000.0 in 2024, then declined by 19.53% to $239000.0 in 2025.
- The last three Other financing activities figures came in at $239000.0 (Q4 2025), $261000.0 (Q2 2025), and $297000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 239,000.00 |
| Jun 30, 2025 | 261,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Jun 30, 2023 | 449,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 643,000.00 |
| Dec 31, 2020 | 1.46 Mn |
| Dec 31, 2019 | 326,000.00 |
| Sep 30, 2019 | 21.82 Mn |
| Jun 30, 2019 | 1,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Jun 30, 2018 | 2.37 Mn |
| Mar 31, 2018 | 512,000.00 |